Position in IQV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$61,228,906
-$41,030,970 QoQ
Shares Held
316,887
-47.2% QoQ
Ownership
0.190%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#72
of 1,082 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Capital World Investors holds $6,483,252,498 across 6 Diagnostics & Research names. IQV ranks #5 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
6,195,370 | $3,106,110,703 | |
| 2 | ILMN |
Illumina, Inc.
|
15,425,298 | $2,712,230,147 | |
| 3 | NTRA |
Natera, Inc.
|
1,504,387 | $408,365,851 | |
| 4 | ICLR |
Icon PLC
|
1,106,056 | $192,132,987 | |
| 5 | IQV |
Iqvia Holdings Inc.
This page
|
316,887 | $61,228,906 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
14,039 | $3,183,904 |
All Filings in IQV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $61,228,906 | 316,887 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $102,259,876 | 599,624 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $134,061,245 | 594,744 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $112,304,684 | 591,264 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $92,953,358 | 589,843 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $103,970,809 | 589,738 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $115,522,333 | 587,870 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $157,986,477 | 666,694 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $140,804,873 | 665,933 | Shares | Defined | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||